Sustained remission at 10 years was more common as well among the patients starting anti-TNFs right away, Toyoda told ...

INmune Bio's XPro1595 targets soluble TNF for Alzheimer's. Phase 2 results could reshape inflammatory disease treatment.

Regulatory authorities issued precautionary recommendations following the ORAL Surveillance trial, which demonstrated an elevated risk of cancer with tofacitinib, compared to TNF inhibitors (TNFi).1 ...

Research findings increasingly indicate close associations between autoimmune thyroid disease and rheumatic disease.

Immunovant faces high R&D costs, limited cash runway, and unproven clinical edge despite pipeline progress and deeper IgG ...

Inflammation, a natural immune response, may affect weight gain by causing insulin resistance and affecting hormones that ...

High blood pressure is caused by a combination of factors, such as age, dietary habits, and coexisting conditions. Learn ...

Understanding how genes behave within their native tissue environment is unlocking new frontiers in medical science. A recent review highlights how ...

About IHL-42X IHL-42X is designed to treat obstructive sleep apnea (“OSA”) by targeting its underlying pathophysiology. An oral fixed-dose combination of dronabinol and acetazolamide, IHL-42X is ...

Prefilled Syringe Drug Molecule Market Prefilled Syringe Drug Market to Hit $133.24B by 2035, Growing from $74.38B in 2025 The pref ...

A follow-up paper has been published, detailing the ongoing health of a group of men who received a one-time gene therapy to ...